Skip to main content
EMR logo

EMR · Emerson Electric Co · Financials

Track EMR — free
$155.10 -2.14 (-1.36%)
Market Cap
$88.26B
Shares
557.80M
Volume · Sep 30 4.65M Avg daily vol (3M) 2.52M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$18.02B +3%
FY2025 Revenue FY2007–FY2025
Net Income
$2.29B +16.5%
FY2025 Net Income FY2007–FY2025
Gross Margin
52.84% +2pp
FY2025 Gross Margin FY2009–FY2025
Diluted EPS
$4.04 +17.8%
FY2025 Diluted EPS FY2007–FY2025
Operating Cash Flow
$3.1B -7%
FY2025 Operating Cash Flow FY2007–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009 FY2008 FY2007
$18.64B $18.02B $17.49B $15.17B $1.66B $12.93BG $16.79B $18.37B $17.41B $15.26B $14.52B $16.25B $17.73B $24.67B $24.41B $24.22B $21.04B $20.1B $23.75B $22.13B
$8.73B $8.5B $8.61B $7.74B $7.5B $7.2B $9.78B $10.56B $9.98B $8.83B $8.26B $9.24B $9.97B $14.72B $14.64B $14.67B $12.71B $12.54B $14.81B $14.07B
— $9.52B $8.89B $7.43B $6.31B $7.56B $7.01B $7.82B $7.43B $6.4B $6.26B $7.01B $10.16B $9.95B $9.77B $9.56B $8.33B $7.56B — —
— 52.84% 50.79% 48.97% 379.88% 58.48% 41.76% 42.54% 42.69% 41.95% 43.12% 43.13% 57.28% 40.34% 40.01% 39.46% 39.57% 37.61% — —
— $771M $781M $523M $385M $347M $439M $454M $436M $340M $320M $336M $356M $576M $547M $555M $473M $460M $458M —
$5.23B $5.1B $5.14B $4.19B $3.61B $3.49B $3.99B $4.46B $4.27B $3.61B $3.46B $3.74B $4.16B $5.65B $5.44B $5.33B $4.82B $4.42B $4.92B $4.57B
— $1.17B $1.37B $764M $530M $432M $369M $359M $314M $222M $177M $174M $167M $298M $318M $345M $254M $184M $150M —
$1.48B $1.52B $1.69B $1.05B $842M $762M $854M $822M $758M $636M $568M $573M $569M $819M $823M $867M $816M $727M $707M $656M
$208M $136M $228M $72M $75M $132M $284M $95M $65M $78M $96M $138M $39M $78M $119M $81M $126M $284M — —
— — — — — $147M — — — — — — — — — — — — — —
$107M $150M $148M $227M $34M $10M $19M $27M $43M $36M $27M $23M $18M $16M $17M $23M $19M $24M $56M $33M
$110M $81M $72M $145M $100M $71M $12M $8M -$61M -$110M -$114M -$98M -$77M -$362M -$401M -$356M -$369M -$474M -$190M -$175M
-$272M — — -$177M $0 $0 — — — — — — -$34M — — — — — — —
$3.28B $2.93B $2.02B $2.9B $2.43B $1.76B $2.34B $2.86B $2.67B $2.34B $2.32B $3.81B $3.19B $3.2B $3.12B $3.63B $2.88B $2.8B $3.65B —
$703M $696M $415M $642M $549M $346M $345M $531M $443M $660M $697M $1.27B $953M $1.13B $1.09B $1.13B $848M $688M $1.13B $964M
$2.58B $2.29B $1.97B $13.22B $3.23B $2.3B $1.97B $2.31B $2.2B $1.52B $1.64B $2.71B $2.15B $2B $1.97B $2.48B $2.16B $1.72B $2.41B $2.14B
— 12.73% 11.25% 87.17% 194.64% 17.81% 11.71% 12.55% 12.66% 9.94% 11.26% 16.68% 12.11% 8.12% 8.06% 10.24% 10.29% 8.58% 10.16% 9.65%
$1M -$47M -$13M -$19M -$1M $24M $25M $22M $21M $32M $29M $23M $37M $62M $56M $50M $53M $47M $74M —
$2.53B $2.34B $2.35B $13.45B $2.62B $3.01B $2.11B $1.6B $2.21B $2.5B $1.25B $1.67B $1.75B $2.55B $1.8B $2.34B — — — —
USD/shares — $4.06 $3.44 $23.00 $5.44 $3.85 $3.26 $3.74 $3.48 $2.35 $2.53 $4.01 $3.05 $2.78 $2.68 $3.29 $2.87 $2.29 $3.09 $2.69
USD/shares — $4.04 $3.43G $22.88 $5.41G $3.82 $3.24G $3.71 $3.46 $2.35 $2.52 $3.99 $3.03 $2.76 $2.67 $3.27 $2.84 $2.27 $3.06 $2.66
shares — 564M 571.3M 574.2M 592.9M 598.1M 602.9M 616.2M 632M 642.1M 644M 673.3M 700.2M 717.7M 730.6M 748.5M 750.7M 753.7M 780.3M —
shares — 566.7M 574M 577.3M 596.3M 601.8M 606.6M 620.6M 635.3M 643.4M 646.8M 676.5M 704.1M 722.9M 734.6M 753.5M 757M 758.7M 789.4M —
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2007–FY2025: $17.98B in buybacks, $21.79B in dividends.

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.
1 filing has incomplete source or extraction coverage. Verified observations are shown; missing observations do not establish that debt was unchanged.

364-Day Credit Facility

RevolvingCreditFacility · Emerson Electric Co.

Reference: 364-Day Credit Facility

Active
Outstanding
—
Commitment
—
Availability
—
Maturity
Feb 9, 2027
Documents and filing history
  1. Issuance · 2026-02-10 Outstanding — · carrying — Exact source document Parent 8-K filing · 2026-02-13
    On February 10, 2026, Emerson Electric Co. (the "Company") entered into a $2 billion 364-Day Credit Agreement (the “364-Day Credit Facility”), dated as of February 10, 2026, with JPMorgan Chase Bank, N.A., as agent, Bank of America, N.A., Citibank, N.A., and Goldman Sachs Bank USA, as syndication agents, and the lenders named therein. The 364-Day Credit Facility expires on February 9, 2027. There are no outstanding loans or letters of credit under the 364 Day Credit Facility. The Company has not incurred any borrowings under this or prior similar facilities, and has no current intention to do so. The 364-Day Credit Facility supports general corporate purposes, including as a liquidity back-up for the Company’s commercial paper borrowings. The facility replaces the Company’s $3 billion 364-Day Credit Agreement entered into on February 11, 2025, which expired by its terms.
    Issuer evidence: On February 10, 2026, Emerson Electric Co. (the "Company") entered into a $2 billion 364-Day Credit Agreement (the “364-Day Credit Facility”), dated as of February 10, 2026, with JPMorgan Chase Bank, N.A., as agent, Bank of America, N.A., Citibank, N.A., and Goldman Sachs Bank USA, as syndication agents, and the lenders named therein. The 364-Day Credit Facility expires on February 9, 2027. There are no outstanding loans or letters of credit under the 364 Day Credit Facility. The Company has not incurred any borrowings under this or prior similar facilities, and has no current intention to do so. The 364-Day Credit Facility supports general corporate purposes, including as a liquidity back-up for the Company’s commercial paper borrowings. The facility replaces the Company’s $3 billion 364-Day Credit Agreement entered into on February 11, 2025, which expired by its terms.
    Supporting evidence: The 364-Day Credit Facility is unsecured and may be accessed under various interest rate alternatives, at the Company’s option. The Company may from time to time designate any of its eligible subsidiaries as subsidiary borrowers under the 364-Day Credit Facility. The Company has unconditionally and irrevocably guaranteed the obligations of each of its subsidiaries in the event a subsidiary is named a borrower under the 364-Day Credit Facility. Loans are denominated in U.S. dollars. The Company must pay facility fees on the aggregate amounts available under the 364-Day Credit Facility, as specified in the credit agreement. The 364-Day Credit Facility contains customary representations, warranties, covenants and events of default.
    Supporting evidence: On February 10, 2026, Emerson Electric Co. (the "Company") entered into a $2 billion 364-Day Credit Agreement (the “364-Day Credit Facility”), dated as of February 10, 2026, with JPMorgan Chase Bank, N.A., as agent, Bank of America, N.A., Citibank, N.A., and Goldman Sachs Bank USA, as syndication agents, and the lenders named therein. The 364-Day Credit Facility expires on February 9, 2027. There are no outstanding loans or letters of credit under the 364 Day Credit Facility. The Company has not incurred any borrowings under this or prior similar facilities, and has no current intention to do so. The 364-Day Credit Facility supports general corporate purposes, including as a liquidity back-up for the Company’s commercial paper borrowings. The facility replaces the Company’s $3 billion 364-Day Credit Agreement entered into on February 11, 2025, which expired by its terms.
    Supporting evidence: On February 10, 2026, Emerson Electric Co. (the "Company") entered into a $2 billion 364-Day Credit Agreement (the “364-Day Credit Facility”), dated as of February 10, 2026, with JPMorgan Chase Bank, N.A., as agent, Bank of America, N.A., Citibank, N.A., and Goldman Sachs Bank USA, as syndication agents, and the lenders named therein. The 364-Day Credit Facility expires on February 9, 2027. There are no outstanding loans or letters of credit under the 364 Day Credit Facility. The Company has not incurred any borrowings under this or prior similar facilities, and has no current intention to do so. The 364-Day Credit Facility supports general corporate purposes, including as a liquidity back-up for the Company’s commercial paper borrowings. The facility replaces the Company’s $3 billion 364-Day Credit Agreement entered into on February 11, 2025, which expired by its terms.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
5.32×
Peer median 4.74×
EV/EBIT
—
Peer median 24.48×
P/E (TTM)
—
Peer median 31.76×

Peer medians compare against the 23 similar-size Specialty Industrial Machinery companies (of 78 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Final Control $4,380,000,000 $4,204,000,000 $3,970,000,000 — — — — —
Control Systems and Software $4,205,000,000 $3,935,000,000 $3,648,000,000 — — — — —
Measurement and Analytical $4,143,000,000 $4,061,000,000 $3,595,000,000 — — — — —
Discrete Automation $2,521,000,000 $2,506,000,000 $2,635,000,000 — — — — —
Test and Measurement $1,486,000,000 $1,464,000,000 $0 — — — — —
Safety and Productivity $1,356,000,000 $1,390,000,000 $1,388,000,000 — — — — —
AspenTech — — — $656,000,000 $319,000,000 $131,000,000 — —
Automation Solutions — — — $11,758,000,000 $11,292,000,000 $11,026,000,000 $12,202,000,000 $11,441,000,000
Climate Technologies — — — $5,200,000,000 $4,748,000,000 $3,980,000,000 $4,313,000,000 $4,454,000,000
Tools Home Products — — — $2,033,000,000 $1,905,000,000 $1,663,000,000 $1,856,000,000 $1,528,000,000

By Geography (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
United States $7,481,000,000 $7,091,000,000 $6,327,000,000 $5,671,000,000 $4,982,000,000 $7,420,000,000 $8,390,000,000 $7,939,000,000
China $1,829,000,000 $1,901,000,000 $1,804,000,000 $1,824,000,000 $1,662,000,000 $1,845,000,000 $1,962,000,000 $1,955,000,000

By Product & Service (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Intelligent Devices $12,400,000,000 $12,161,000,000 $11,588,000,000 $10,836,000,000 $10,380,000,000 — — —
Software and Control $5,691,000,000 $5,399,000,000 $3,648,000,000 $3,054,000,000 $2,640,000,000 — — —
Industrial Solutions — — — — — $2,012,000,000 $2,232,000,000 $1,967,000,000
Measurement Analytical Instrumentation — — — — — $3,108,000,000 $3,615,000,000 $3,604,000,000
Process Control Systems Solutions — — — — — $2,317,000,000 $2,561,000,000 $2,121,000,000
Valves Actuators Regulators — — — — — $3,589,000,000 $3,794,000,000 $3,749,000,000
Key facts CIK 32604 CUSIP 291011104 13F (30d) 43 filings 25 filers Visit website Investor relations